Crossref
Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome
Yearbook of Paediatric Endocrinology · 30.09.2025
DOI: 10.1530/ey.22.2.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Brouchoven Isabel De und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
De, B. I., Lorand, J., Bofferding,, A. S. L., Van, D. A., & Danhaive, O. (2025). Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.2.5
Vancouver
De BI, Lorand J, Bofferding, ASL, Van DA, Danhaive O. Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.2.5
BibTeX
@article{De2025,
author = {De, Brouchoven Isabel and Lorand, Juan and Bofferding,, Arthur Sorlin Leon and Van, Damme An and Danhaive, Olivier},
title = {Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome},
journal = {Yearbook of Paediatric Endocrinology},
year = {2025},
doi = {10.1530/ey.22.2.5}
}
EUVIMED